Synopsis
Synopsis
0
CEP/COS
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1,3-dimethyl-5-aminoadamantane
2. 1-amino-3,5-dimethyladamantane
3. Axura
4. D 145
5. D-145
6. D145
7. Ebixa
8. Memantin
9. Memantine
10. Namenda
1. 41100-52-1
2. Memantine Hcl
3. Namenda
4. 3,5-dimethyl-1-adamantanamine Hydrochloride
5. 3,5-dimethyladamantan-1-amine Hydrochloride
6. Akatinol
7. Axura
8. Namenda Xr
9. Memary
10. Ebixa
11. Memantine Mylan
12. 1-amino-3,5-dimethyladamantane Hydrochloride
13. Memantine Merz
14. Memantine.hcl
15. Memantine Accord
16. Memantine Lek
17. Memantine (hydrochloride)
18. Acrescent
19. Balaxur
20. Auxura
21. Unii-jy0wd0ua60
22. 3,5-dimethyladamantan-1-amine;hydrochloride
23. Jy0wd0ua60
24. Mfcd00214336
25. Memantine Ratiopharm
26. Memantine Hydrochloride [usan]
27. Chebi:64323
28. Sun-y7017
29. Nsc-102290
30. 3,5-dimethyladamantan-1-aminium Chloride
31. D-145
32. Mls001332605
33. 3,5-dimethyl-1-aminoadamantane Hydrochloride
34. (3,5-dimethyl-1-adamantyl)amine Hydrochloride
35. 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine Hydrochloride
36. Fp-01
37. 1,3-dimethyl-5-adamantanamine Hcl
38. 3,5-dimethyltricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
39. 41100-52-1 (hcl)
40. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride
41. D 145
42. Mantine
43. Ebixza
44. 3,5-dimethyl-tricyclo[3.3.1.13,7]decan-1-amine Hydrochloride
45. 3,5-dimethyltricyclo(3.3.1.13,7)decan-1-amine Hydrochloride
46. 3,5-dimethyltricyclo(3.3.1.1(sup 3,7))decan-1-amine Hydrochloride
47. Tricyclo(3.3.1.1(sup 3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
48. 3,5-dimethyl-1-adamantylamine
49. 3,5-dimethyl-1-aminoadamantane
50. Smr000875213
51. Sr-01000075458
52. Sun Y7017
53. Einecs 255-219-6
54. Namenda (tn)
55. Memary (tn)
56. Marixino
57. Nsc 102290
58. D-145 (hydrochloride)
59. Schembl3053
60. C12h21n.hcl
61. Chembl1699
62. Mls001332606
63. Spectrum1501121
64. Hy-b0365a
65. Dtxsid90961439
66. Memantine Hydrochloride (namenda)
67. N06dx01
68. Nmi-131
69. Hms1571c17
70. Hms1921h03
71. Pharmakon1600-01501121
72. Memantine Hydrochloride (jan/usp)
73. Memantine Hydrochloride [mi]
74. Tox21_500861
75. Ac-559
76. Ccg-39018
77. Memantine Hydrochloride [jan]
78. Mrz-2/145
79. Nsc102290
80. Nsc757843
81. S2043
82. Akos015889460
83. Bcp9000253
84. Lp00861
85. Memantine Hydrochloride [mart.]
86. Nc00680
87. Memantine Hydrochloride [usp-rs]
88. Memantine Hydrochloride [who-dd]
89. Ncgc00094186-01
90. Ncgc00094186-02
91. Ncgc00094186-03
92. Ncgc00261546-01
93. As-13331
94. Bm164662
95. Memantine Hydrochloride [ema Epar]
96. Sy057917
97. 3,5-dimethyladamantan-1-aminehydrochloride
98. Am20070534
99. D3608
100. Eu-0100861
101. Ft-0650723
102. M-145
103. Memantine Hydrochloride [orange Book]
104. Sw060653-4
105. 1-amino-3,5-dimethyl-adamantane Hydrochloride
106. 3,5-dimethyladamantan-1-amine Hy-drochloride
107. 3,5-dimethyladamantan-1-amine;hydrochloride.
108. D04905
109. M 9292
110. Memantine Hydrochloride [usp Monograph]
111. Namzaric Component Memantine Hydrochloride
112. Memantine Hydrochloride Component Of Namzaric
113. Sr-01000075458-1
114. Sr-01000075458-3
115. Sr-01000075458-8
116. Q27133218
117. Z1551429722
118. Tricyclo(3.3.1.1(3,7))decan-1-amine, 3,5-dimethyl-, Hydrochloride
119. Tricyclo[3.3.1.13,7]decan-1-amine, 3,5-dimethyl-, Hydrochloride (1:1) (ca Index Name)
120. 1-amino-3,5-dimethyladamantane . Hcl 3,5-dimethyl-1-aminoadamantane . Hcl Memantine . Hydrochloride
Molecular Weight | 215.76 g/mol |
---|---|
Molecular Formula | C12H22ClN |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Exact Mass | 215.1440774 g/mol |
Monoisotopic Mass | 215.1440774 g/mol |
Topological Polar Surface Area | 26 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 240 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Memantine hydrochloride |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 5mg; 10mg |
Market Status | Tentative Approval |
Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
2 of 6 | |
---|---|
Drug Name | Namenda |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2mg/ml; 5mg; 10mg |
Market Status | Prescription |
Company | Forest Labs |
3 of 6 | |
---|---|
Drug Name | Namenda xr |
Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 7mg; 14mg; 21mg; 28mg |
Market Status | Prescription |
Company | Forest Labs |
4 of 6 | |
---|---|
Drug Name | Memantine hydrochloride |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet |
Route | oral; Oral |
Strength | 5mg; 10mg |
Market Status | Tentative Approval |
Company | Amneal Pharms; Alembic; Upsher Smith; Mylan Pharma; Unichem Pharms (usa); Apotex; Lupin Pharms; Aurobindo Pharma; Torrent Pharms; Macleods Pharms; Jubilant Life |
5 of 6 | |
---|---|
Drug Name | Namenda |
PubMed Health | Memantine (By mouth) |
Drug Classes | Central Nervous System Agent |
Drug Label | Namenda (memantine hydrochloride) is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21N... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Tablet; Solution |
Route | Oral |
Strength | 2mg/ml; 5mg; 10mg |
Market Status | Prescription |
Company | Forest Labs |
6 of 6 | |
---|---|
Drug Name | Namenda xr |
Drug Label | NAMENDA XR is an orally active NMDA receptor antagonist. The chemical name for memantine hydrochloride is 1-amino-3,5-dimethyladamantane hydrochloride with the following structural formula: The molecular formula is C12H21NHCl and the molecular wei... |
Active Ingredient | Memantine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 7mg; 14mg; 21mg; 28mg |
Market Status | Prescription |
Company | Forest Labs |
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimer's disease.
Treatment of patients with moderate to severe Alzheimers disease
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of patients with moderate to severe Alzheimers disease.
Treatment of Alzheimers disease
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Dopamine Agents
Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. (See all compounds classified as Dopamine Agents.)
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06DX01
N06D
N06DA52
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Memantine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Memantine Hydrochloride, including repackagers and relabelers. The FDA regulates Memantine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Memantine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Memantine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Memantine Hydrochloride supplier is an individual or a company that provides Memantine Hydrochloride active pharmaceutical ingredient (API) or Memantine Hydrochloride finished formulations upon request. The Memantine Hydrochloride suppliers may include Memantine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Memantine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Memantine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Memantine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Memantine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Memantine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Memantine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Memantine Hydrochloride USDMF includes data on Memantine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Memantine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Memantine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Memantine Hydrochloride Drug Master File in Japan (Memantine Hydrochloride JDMF) empowers Memantine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Memantine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Memantine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Memantine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Memantine Hydrochloride Drug Master File in Korea (Memantine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Memantine Hydrochloride. The MFDS reviews the Memantine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Memantine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Memantine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Memantine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Memantine Hydrochloride suppliers with KDMF on PharmaCompass.
A Memantine Hydrochloride written confirmation (Memantine Hydrochloride WC) is an official document issued by a regulatory agency to a Memantine Hydrochloride manufacturer, verifying that the manufacturing facility of a Memantine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Memantine Hydrochloride APIs or Memantine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Memantine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Memantine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Memantine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Memantine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Memantine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Memantine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Memantine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Memantine Hydrochloride suppliers with NDC on PharmaCompass.
Memantine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Memantine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Memantine Hydrochloride GMP manufacturer or Memantine Hydrochloride GMP API supplier for your needs.
A Memantine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Memantine Hydrochloride's compliance with Memantine Hydrochloride specifications and serves as a tool for batch-level quality control.
Memantine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Memantine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Memantine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Memantine Hydrochloride EP), Memantine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Memantine Hydrochloride USP).
LOOKING FOR A SUPPLIER?